These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 11527611)

  • 1. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era.
    Mercado N; Boersma E; Wijns W; Gersh BJ; Morillo CA; de Valk V; van Es GA; Grobbee DE; Serruys PW
    J Am Coll Cardiol; 2001 Sep; 38(3):645-52. PubMed ID: 11527611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents.
    Hoffmann R; Mintz GS; Mehran R; Pichard AD; Kent KM; Satler LF; Popma JJ; Wu H; Leon MB
    J Am Coll Cardiol; 1998 Jan; 31(1):43-9. PubMed ID: 9426016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. Austrian Wiktor Stent Study Group and European Paragon Stent Investigators.
    Gyöngyösi M; Yang P; Khorsand A; Glogar D
    J Am Coll Cardiol; 2000 May; 35(6):1580-9. PubMed ID: 10807464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of restenosis after coronary stent placement.
    Kastrati A; Schömig A; Elezi S; Schühlen H; Dirschinger J; Hadamitzky M; Wehinger A; Hausleiter J; Walter H; Neumann FJ
    J Am Coll Cardiol; 1997 Nov; 30(6):1428-36. PubMed ID: 9362398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long-term follow-up results.
    Rodríguez A; Ayala F; Bernardi V; Santaera O; Marchand E; Pardiñas C; Mauvecin C; Vogel D; Harrell LC; Palacios IF
    J Am Coll Cardiol; 1998 Nov; 32(5):1351-7. PubMed ID: 9809947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month outcome after excimer laser coronary angioplasty for diffuse in-stent restenosis in native coronary arteries.
    Hamburger JN; Foley DP; de Feyter PJ; Wardeh AJ; Serruys PW
    Am J Cardiol; 2000 Aug; 86(4):390-4. PubMed ID: 10946030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenting of nonacute total coronary occlusions: predictors of late angiographic outcome.
    Rau T; Schofer J; Schlüter M; Seidensticker A; Berger J; Mathey DG
    J Am Coll Cardiol; 1998 Feb; 31(2):275-80. PubMed ID: 9462567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries.
    Serruys PW; Kay IP; Disco C; Deshpande NV; de Feyter PJ
    J Am Coll Cardiol; 1999 Oct; 34(4):1067-74. PubMed ID: 10520792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results.
    Mehran R; Dangas G; Abizaid A; Lansky AJ; Mintz GS; Pichard AD; Satler LF; Kent KM; Waksman R; Stone GW; Leon MB
    Am Heart J; 2001 Apr; 141(4):610-4. PubMed ID: 11275928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary stenting or balloon angioplasty for chronic total coronary occlusions: the Taiwan experience (a single-center report).
    Fang CC; Jao YT; Chen Y; Wang SP
    Angiology; 2005; 56(5):525-37. PubMed ID: 16193191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus.
    Mazeika P; Prasad N; Bui S; Seidelin PH
    Am Heart J; 2003 Jun; 145(6):1013-21. PubMed ID: 12796757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone.
    Mehran R; Mintz GS; Satler LF; Pichard AD; Kent KM; Bucher TA; Popma JJ; Leon MB
    Circulation; 1997 Oct; 96(7):2183-9. PubMed ID: 9337188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
    Melkert R; Violaris AG; Serruys PW
    J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
    Serruys PW; Foley DP; Suttorp MJ; Rensing BJ; Suryapranata H; Materne P; van den Bos A; Benit E; Anzuini A; Rutsch W; Legrand V; Dawkins K; Cobaugh M; Bressers M; Backx B; Wijns W; Colombo A
    J Am Coll Cardiol; 2002 Feb; 39(3):393-9. PubMed ID: 11823075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.
    Herrmann HC; Buchbinder M; Clemen MW; Fischman D; Goldberg S; Leon MB; Schatz RA; Tierstein P; Walker CM; Hirshfeld JW
    Circulation; 1992 Sep; 86(3):812-9. PubMed ID: 1516193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-energy eccentric excimer laser angioplasty for debulking diffuse iIn-stent restenosis leads to better acute- and 6-month follow-up results.
    Dahm JB; Kuon E
    J Invasive Cardiol; 2000 Jul; 12(7):335-42. PubMed ID: 10904438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.
    Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM
    Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.